Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8883)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2017 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stine JG, Argo CK, Pelletier SJ, Maluf DG, Caldwell SH, Northup PG. Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis. World J Hepatol 2017; 9(3): 139-146 [PMID: 28217250 DOI: 10.4254/wjh.v9.i3.139] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i3/139.htm |
| Number | Citing Articles |
| 1 |
Jonathan G. Stine, Jennifer Wang, Puja M. Shah, Curtis K. Argo, Nicolas Intagliata, Andre Uflacker, Stephen H. Caldwell, Patrick G. Northup. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case‐control study. Liver International 2018; 38(1): 94 doi: 10.1111/liv.13500
|
| 2 |
C. Hobeika, M. Ronot, A. Beaufrere, V. Paradis, O. Soubrane, F. Cauchy. Metabolic syndrome and hepatic surgery. Journal of Visceral Surgery 2020; 157(3): 231 doi: 10.1016/j.jviscsurg.2019.11.004
|
| 3 |
Brian L. Shaw, Bill S. Majdalany, Carlos E. Marroquin. Liver Transplantation - Challenges and Opportunities. 2024; doi: 10.5772/intechopen.1003845
|
| 4 |
Ivana Mikolasevic, Tajana Filipec-Kanizaj, Maja Mijic, Ivan Jakopcic, Sandra Milic, Irena Hrstic, Nikola Sobocan, Davor Stimac, Patrizia Burra. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?. World Journal of Gastroenterology 2018; 24(14): 1491-1506 doi: 10.3748/wjg.v24.i14.1491
|
| 5 |
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, Arnulf Ferlitsch, Christian Datz, Tilmann Gräter, Ivo Graziadei, Michael Gschwantler, Stephanie Hametner-Schreil, Harald Hofer, Mathias Jachs, Alexander Loizides, Andreas Maieron, Markus Peck-Radosavljevic, Florian Rainer, Bernhard Scheiner, Georg Semmler, Lukas Reider, Silvia Reiter, Maria Schoder, Rainer Schöfl, Philipp Schwabl, Vanessa Stadlbauer, Rudolf Stauber, Elisabeth Tatscher, Michael Trauner, Alexander Ziachehabi, Heinz Zoller, Peter Fickert, Thomas Reiberger. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV). Wiener klinische Wochenschrift 2023; 135(S3): 493 doi: 10.1007/s00508-023-02229-w
|
| 6 |
Daniel Gaballa, Dmitri Bezinover, Zakiyah Kadry, Elaine Eyster, Ming Wang, Patrick G. Northup, Jonathan G. Stine. Development of a Model to Predict Portal Vein Thrombosis in Liver Transplant Candidates: The Portal Vein Thrombosis Risk Index. Liver Transplantation 2019; 25(12): 1747 doi: 10.1002/lt.25630
|
| 7 |
Peter L. Wang, Vijay Ramalingam, Lauren M. Yang. Portal Vein Thrombosis in Patients with Cirrhosis. Current Hepatology Reports 2024; 23(1): 64 doi: 10.1007/s11901-024-00636-9
|
| 8 |
Andy Liu, Artin Galoosian, Dharmesh Kaswala, Andrew A. Li, Chiranjeevi Gadiparthi, George Cholankeril, Donghee Kim, Aijaz Ahmed. Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft. Journal of Clinical and Translational Hepatology 2018; 6(3): 1 doi: 10.14218/JCTH.2018.00010
|
| 9 |
Patrick G. Northup, Juan Carlos Garcia‐Pagan, Guadalupe Garcia‐Tsao, Nicolas M. Intagliata, Riccardo A. Superina, Lara N. Roberts, Ton Lisman, Dominique C. Valla. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 73(1): 366 doi: 10.1002/hep.31646
|
| 10 |
Jonathan G. Stine, Blake A. Niccum, Alex N. Zimmet, Nicolas Intagliata, Stephen H. Caldwell, Curtis K. Argo, Patrick G. Northup. Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis. Clinical and Translational Gastroenterology 2018; 9(3): e140 doi: 10.1038/s41424-018-0002-y
|
| 11 |
Jonathan G. Stine, Ian Schreibman, Seyedehsan Navabi, Mitchell Kang, Jessica Dahmus, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Megan Beyer, Heather Tressler, Scot R. Kimball, Andrew D. Patterson, Kathryn Schmitz, Christopher Sciamanna. Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. Contemporary Clinical Trials Communications 2020; 18: 100560 doi: 10.1016/j.conctc.2020.100560
|
| 12 |
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
|
| 13 |
Abdel-Rauf Zeina, Yael Kopelman, Amir Mari, Helal Said Ahmad, Suheil Artul, Ali Sleman Khalaila, Randa Taher, Fernando Zertuche Villannueva, Rabea Safadi, Saif Abu Mouch, Fadi Abu Baker. Pulmonary embolism risk in hospitalized patients with nonalcoholic fatty liver disease: A case-control study. Medicine 2022; 101(45): e31710 doi: 10.1097/MD.0000000000031710
|
| 14 |
Jonathan G. Stine, Ian R. Schreibman, Alison J. Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Scot R. Kimball, Nate R. Geyer, Vernon M. Chinchilli, Rohit Loomba, Kathryn Schmitz, Christopher Sciamanna. NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH. Hepatology 2022; 76(1): 172 doi: 10.1002/hep.32274
|
| 15 |
Waseem Amjad, Zhenghui G. Jiang, Michelle Lai. Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis. European Journal of Gastroenterology & Hepatology 2024; 36(8): 1038 doi: 10.1097/MEG.0000000000002800
|
| 16 |
Plessier Aurélie, Maxime Gasperment, Dominique Debray, Emilie Le Beux, Corinne Brault, Isabelle Ollivier-Hourmand, Danielle Dutheil, Anne Leclercq, Julie Devictor, Virginia Hernández-Gea, Rautou Pierre Emmanuel, Odile Goria. Social and medical support initiatives in vascular liver diseases in France, from child to adult. Clinics and Research in Hepatology and Gastroenterology 2020; 44(4): 466 doi: 10.1016/j.clinre.2020.03.002
|
| 17 |
倩 刘. Research Progress on Etiology of Cirrhosis with Portal Vein Thrombosis. Advances in Clinical Medicine 2020; 10(03): 185 doi: 10.12677/ACM.2020.103030
|
| 18 |
Manus Rugivarodom, Phunchai Charatcharoenwitthaya. Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. Journal of Clinical and Translational Hepatology 2020; 9(1): 1 doi: 10.14218/JCTH.2020.00067
|
| 19 |
Michael Schwarz, Caroline Schwarz, Lukas Burghart, Nikolaus Pfisterer, David Bauer, Wolfgang Hübl, Mattias Mandorfer, Michael Gschwantler, Thomas Reiberger, Ashraf Elbahrawy. Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes. PLOS ONE 2023; 18(8): e0290352 doi: 10.1371/journal.pone.0290352
|
| 20 |
Fuat H. Saner, Ecaterina Scarlatescu, Dieter Clemens Broering, Dmitri Bezinover. The Yin and the Yang of Hemostasis in End-Stage Liver Disease. Journal of Clinical Medicine 2023; 12(17): 5759 doi: 10.3390/jcm12175759
|
| 21 |
Marco Biolato, Mattia Paratore, Luca Di Gialleonardo, Giuseppe Marrone, Antonio Grieco. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?. World Journal of Hepatology 2022; 14(4): 682-695 doi: 10.4254/wjh.v14.i4.682
|
| 22 |
Francisco Capinha, Carlos Noronha Ferreira. Management of Nonmalignant Portal Vein Thrombosis in Cirrhosis. GE - Portuguese Journal of Gastroenterology 2024; 31(2): 77 doi: 10.1159/000533161
|
| 23 |
Wasim A. Dar, Elise Sullivan, John S. Bynon, Holger Eltzschig, Cynthia Ju. Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms. Liver International 2019; 39(5): 788 doi: 10.1111/liv.14091
|
| 24 |
The Effect of Obesity on the State of Platelet-plasma Hemostasis in Patients with Essential Hypertension in Combination with Non-alcoholic Fatty Liver Disease. Family medicine 2020; (4): 56 doi: 10.30841/2307-5112.4.2020.217657
|
| 25 |
E Pardina, R Ferrer, J Rossell, D Ricart-Jané, K A Méndez-Lara, J A Baena-Fustegueras, A Lecube, J Julve, J Peinado-Onsurbe. Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery. International Journal of Obesity 2017; 41(9): 1388 doi: 10.1038/ijo.2017.115
|
| 26 |
Jonathan G. Stine, Dmitri Bezinover, Zakiyah Kadry. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. Liver Transplantation 2018; 24(7): 976 doi: 10.1002/lt.25064
|
| 27 |
Oana Nicoară-Farcău, Guillem Soy, Marta Magaz, Anna Baiges, Fanny Turon, Angeles Garcia-Criado, Marta Barrufet, Marta Burrel, Virginia Hernández-Gea, Juan Carlos García-Pagán. New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis. Seminars in Thrombosis and Hemostasis 2020; 46(06): 673 doi: 10.1055/s-0040-1715473
|
| 28 |
Paras Garg, Barry Harrison, Edward J. Gane. Incident portal vein thrombosis in liver transplant recipients in New Zealand: Predictors of risk and validation of portal vein thrombosis risk index calculator. Frontiers in Transplantation 2022; 1 doi: 10.3389/frtra.2022.1042684
|
| 29 |
Jessica P. E. Davis, Nicolas M. Intagliata. The Critically Ill Cirrhotic Patient. 2020; : 219 doi: 10.1007/978-3-030-24490-3_12
|
| 30 |
Magnus Holmer, Espen Melum, Helena Isoniemi, Bo‐Göran Ericzon, Maria Castedal, Arno Nordin, Nicolai Aagaard Schultz, Allan Rasmussen, Pål‐Dag Line, Per Stål, William Bennet, Hannes Hagström. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries. Liver International 2018; 38(11): 2082 doi: 10.1111/liv.13751
|
| 31 |
Gloriany Rivas, Breianna Hummer-Bair, Dmitri Bezinover, Zakiyah Kadry, Jonathan Stine. Plasminogen activator inhibitor is significantly elevated in liver transplant recipients with decompensated NASH cirrhosis. BMJ Open Gastroenterology 2021; 8(1): e000683 doi: 10.1136/bmjgast-2021-000683
|
| 32 |
Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi. Is non-alcoholic fatty liver disease a prothrombotic risk factor?. Bleeding, Thrombosis, and Vascular Biology 2023; 2(2) doi: 10.4081/btvb.2023.81
|
| 33 |
C. Hobeika, M. Ronot, A. Beaufrere, V. Paradis, O. Soubrane, F. Cauchy. Syndrome métabolique et chirurgie hépatique. Journal de Chirurgie Viscérale 2020; 157(3): 235 doi: 10.1016/j.jchirv.2019.08.004
|
| 34 |
Stefano Ballestri, Mariano Capitelli, Maria Cristina Fontana, Dimitriy Arioli, Elisa Romagnoli, Catia Graziosi, Amedeo Lonardo, Marco Marietta, Francesco Dentali, Giorgio Cioni. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative Review. Advances in Therapy 2020; 37(5): 1910 doi: 10.1007/s12325-020-01307-z
|
| 35 |
|
| 36 |
Mariella Faccia, Maria Elena Ainora, Francesca Romana Ponziani, Laura Riccardi, Matteo Garcovich, Antonio Gasbarrini, Maurizio Pompili, Maria Assunta Zocco. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World Journal of Gastroenterology 2019; 25(31): 4437-4451 doi: 10.3748/wjg.v25.i31.4437
|
| 37 |
Roberta Stupia, Rosa Lombardi, Filippo Cattazzo, Mirko Zoncapè, Anna Mantovani, Leonardo De Marco, Alessandro Mantovani, Anna Ludovica Fracanzani, David Sacerdoti, Andrea Dalbeni. Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies. Journal of Thrombosis and Thrombolysis 2023; 57(2): 330 doi: 10.1007/s11239-023-02912-9
|
| 38 |
Sonal Sharma, Jonathan G. Stine, Thomas Verbeek, Dmitri Bezinover. Management of Patients With Non-alcoholic Steatohepatitis Undergoing Liver Transplantation: Considerations for the Anesthesiologist. Journal of Cardiothoracic and Vascular Anesthesia 2022; 36(8): 2616 doi: 10.1053/j.jvca.2021.07.020
|
| 39 |
Liana Gheorghe, Speranta Iacob. Alcohol and Alcohol-related Diseases. 2023; : 837 doi: 10.1007/978-3-031-32483-3_45
|